SiHa cells which were pretreated with BIX01294 or vehicle were used to evaluate whether G9a promotes cervical cancer cell invasiveness in vivo; this was done by analyzing the intravasation phenotype using an in vivo CAM assay. This evidence concerns the gene EHMT2 and cervical carcinoma.